Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Range Nuclear Renaissance ETF (NUKZ) vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) Price & Performance

Range Nuclear Renaissance ETFTrade
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)Trade

Price performance (Past 24H)

Key statistics

Range Nuclear Renaissance ETF vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) — how do they compare? Range Nuclear Renaissance ETF trades at $61.06 (market cap $698.21M), while Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.71 (market cap $58.74B). The key difference: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) is far larger — about 84.1× Range Nuclear Renaissance ETF's market cap, and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) pays a 3.33% dividend while Range Nuclear Renaissance ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Range Nuclear Renaissance ETF for 18 Days and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 1 Days on average.

NUKZTAK
Market Cap
$698.21M$58.74B
Volume
57,4443,110,994
Sector
Sector/ThematicHealth
52-Week High
$76.23$19.05
52-Week Low
$60.23$13.23
Typical Hold Time
18 Days1 Days
Enterprise Value
—$86.65B
Dividend Yield
—3.33%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Range Nuclear Renaissance ETF

Range Nuclear Renaissance ETF seeks to track companies related to the nuclear energy industry. Its holdings may include businesses involved in uranium, nuclear power generation, reactors, and nuclear services.

Read more on NUKZ →

About Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.

Read more on TAK →